Correlation Between Enanta Pharmaceuticals and Tilray

Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Tilray at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Tilray into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enanta Pharmaceuticals and Tilray Inc, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Tilray and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Tilray. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Tilray.

Diversification Opportunities for Enanta Pharmaceuticals and Tilray

0.79

Correlation Coefficient

Enanta Pharmaceuticals  Tilray

Poor diversification

The 3 months correlation between Enanta and Tilray is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Tilray Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tilray Inc and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Tilray. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tilray Inc has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Tilray go up and down completely randomly.

Pair Corralation between Enanta Pharmaceuticals and Tilray

Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Tilray. But the stock apears to be less risky and, when comparing its historical volatility, Enanta Pharmaceuticals is 1.02 times less risky than Tilray. The stock trades about -0.17 of its potential returns per unit of risk. The Tilray Inc is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest  170.00  in Tilray Inc on September 12, 2024 and sell it today you would lose (47.50) from holding Tilray Inc or give up 27.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Enanta Pharmaceuticals  vs.  Tilray Inc

Enanta Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enanta Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Tilray Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tilray Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Enanta Pharmaceuticals and Tilray

The main advantage of trading using opposite Enanta Pharmaceuticals and Tilray positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Tilray can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tilray will offset losses from the drop in Tilray's long position.

The idea behind Enanta Pharmaceuticals and Tilray Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.